Pharm
Bexarotene
search
Bexarotene
, Targretin
See Also
Chemotherapy
Cutaneous T-Cell Lymphoma
Retinoid
Indications
Cutaneous T-Cell Lymphoma
(refractory)
Mechanism
Synthetic
Retinoid
(
Retinoic Acid
analog) with antineoplastic activity, used in
T-Cell Lymphoma
Bexarotene binds
Retinoid
X receptors (RXRs include RXR-a, RXR-b, RXR-y)
Bound receptors act as transcription factors that alter gene expression
Receptor binding promotes increased cell differentiation and decreased cell proliferation
Induces apoptosis and
Cutaneous T-Cell Lymphoma
tumor regression
Medications
Bexarotene oral capsules: 75 mg
Bexarotene gel 1%
Avoid applying gel under
Occlusive Dressing
s
Avoid use in combination with
DEET
Dosing
See other references for disease specific dosing protocols
Adverse Effects
Topical Gel
Contact Dermatitis
Pruritus
Adverse Effects
Capsules (Systemic)
Alopecia
Cataract
s
Hepatotoxicity (increased
Liver Function Test
s)
Hyperlipidemia
Hypothyroidism
Leukopenia
Pancreatitis
Photosensitivity
Safety
Avoid in
Lactation
Avoid in pregnancy (all trimesters)
Systemic
Retinoid
s are associated with severe birth defects
Use reliable
Contraception
, with at least one form that is a non-hormonal (see
Drug Interaction
s below)
Monitoring (systemic capsules)
Complete Blood Count
Lipid
profile
Liver Function Test
s
Thyroid Function Test
s
Drug Interactions
Capsules (Systemic)
Other agents that increase Bexarotene levels
Gemfibrozil
CYP3A4
Inducer
May decrease activity of drugs metabolized by
CYP3A4
including
Oral Contraceptive
s
Resources
Bexarotene Capsules (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d7fc7c7b-2ecf-4543-8bb4-9b4415d66613
Bexarotene
Topical Gel
(DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d35b4697-3f3b-4aa1-b5d9-153993e83811
Type your search phrase here